Inaktiver Wert

MAP Pharmaceuticals Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	26.01.13
MAP Pharmaceuticals Inc. : Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.	24.01.13
MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	24.01.13
MAP Pharmaceuticals Inc. : INVESTOR ALERT: Brannon Law Firm, L.L.C. is Investigating the Proposed Tender Offer/Merger of MAP Pharmaceuticals, Inc. by Allergan, Inc.	23.01.13
MAP Pharmaceuticals Inc. : Law Firm Brower Piven Announces Investigation of MAP Pharmaceuticals, Inc.	23.01.13

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-1,17 %	102 Mrd.
REGENERON PHARMACEUTICALS, INC.	+2,87 %	96,09 Mrd.
ARGENX SE	+2,13 %	22,28 Mrd.
BIONTECH SE	-14,77 %	21,4 Mrd.
GENMAB A/S	-8,79 %	18,14 Mrd.
WUXI APPTEC CO., LTD.	-39,98 %	17,02 Mrd.
BEIGENE, LTD.	-13,21 %	16,09 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+8,55 %	13,83 Mrd.
SAREPTA THERAPEUTICS, INC.	+35,75 %	11,97 Mrd.